eMation will be supplying its device relationship management solutions to Japanese firm Ricoh, Israeli digital printer maker Scitex Corporation (Nasdaq:SCIX) and Varian Medical Systems (NYSE:VAR), a leader in oncology treatment techniques.
eMation technology control devices and systems remotely via the Internet, enabling companies to monitor machinery from other locations.
In recent months eMation hit the headlines by virtue of its high expenditure rate, some $25 million over a year and a half.
In June this year eMation merged with shell company Ravisent Technologies (Nasdaq:RVST) in an $18.9 million stock swap.
Ravisent shareholders were supposed to convene and approve the transaction a month ago. But the assembly was delayed after the September terrorist attacks on the United States.
Until approval is obtained eMation cannot reveal the value of the deals, but TheMarker.com has learned that they come to about $3.5 million.
EMation was founded in 1988. In 2000, it changed its business strategy to focus on DRM solutions. In May 2000 it secured $25 million at a post-money company value of $70 million.